Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chrolavicius

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Cardiology|October 11, 2011
The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trialAndre Lamy, Wesley Tong, Peggy Gao, et al.
The New England Journal of Medicine|April 2, 2009
Effect of clopidogrel added to aspirin in patients with atrial fibrillation, Stuart J Connolly, Janice Pogue, et al.
European Heart Journal|August 6, 2010
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-WRaffaele De Caterina, Stuart J Connolly, Janice Pogue, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
Journal of the American College of Cardiology|November 16, 2005
Differences in the management and prognosis of women and men who suffer from acute coronary syndromesSonia S Anand, Chang Chun Xie, Shamir Mehta, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 8, 2004
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE studyAndre Lamy, Bengt Jönsson, William S Weintraub, et al.
The New England Journal of Medicine|March 11, 2011
Irbesartan in patients with atrial fibrillation, Salim Yusuf, Jeff S Healey, et al.
American Heart Journal|November 27, 2008
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategyShamir R Mehta, Jean-Pierre Bassand, Susan Chrolavicius, et al.
Circulation|September 25, 2002
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groupsAndrzej Budaj, Salim Yusuf, Shamir R Mehta, et al.
American Heart Journal|December 15, 2010
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trialTjeerd E van Rees Vellinga, Ron J G Peters, Salim Yusuf, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Cardiology|October 11, 2011
The cost of clopidogrel use in atrial fibrillation in the ACTIVE-A trialAndre Lamy, Wesley Tong, Peggy Gao, et al.
The New England Journal of Medicine|April 2, 2009
Effect of clopidogrel added to aspirin in patients with atrial fibrillation, Stuart J Connolly, Janice Pogue, et al.
European Heart Journal|August 6, 2010
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-WRaffaele De Caterina, Stuart J Connolly, Janice Pogue, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
Journal of the American College of Cardiology|November 16, 2005
Differences in the management and prognosis of women and men who suffer from acute coronary syndromesSonia S Anand, Chang Chun Xie, Shamir Mehta, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 8, 2004
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE studyAndre Lamy, Bengt Jönsson, William S Weintraub, et al.
The New England Journal of Medicine|March 11, 2011
Irbesartan in patients with atrial fibrillation, Salim Yusuf, Jeff S Healey, et al.
American Heart Journal|November 27, 2008
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategyShamir R Mehta, Jean-Pierre Bassand, Susan Chrolavicius, et al.
Circulation|September 25, 2002
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groupsAndrzej Budaj, Salim Yusuf, Shamir R Mehta, et al.
American Heart Journal|December 15, 2010
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trialTjeerd E van Rees Vellinga, Ron J G Peters, Salim Yusuf, et al.
Pageof 4